• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描代谢参数可半定量评估心脏和心包肿块的性质:一项回顾性研究。

F-FDG PET/CT metabolic parameters can semi-quantitatively evaluate the nature of the heart and pericardial masses: a retrospective study.

机构信息

Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563000, China.

出版信息

Sci Rep. 2024 Jul 15;14(1):16316. doi: 10.1038/s41598-024-67336-8.

DOI:10.1038/s41598-024-67336-8
PMID:39009884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11251084/
Abstract

The objective of this study was to evaluate semi-quantitatively the diagnostic performance of PET/CT metabolic parameters in differentiating benign or malignant cardiac or pericardial masses. A total of forty-one patients with newly diagnosed cardiac/pericardial masses who underwent F-FDG PET/CT were recruited. PET/CT metabolic parameters including the maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), total lesion glycolysis (TLG), tumor metabolic volume (MTV), the maximum tumor-to-mediastinal background ratio (TMR) and the maximum tumor-to-liver background ratio (TLR) is measured or calculated to evaluate the benign or malignant nature of cardiac/pericardial masses. Compared with benign cardiac/pericardial lesions, cardiac/pericardial malignancies had higher SUVmax, SUVmean, TLG, MTV, TMR, and TLR. All these PET/CT metabolic parameters showed high diagnostic performance in semi-quantitative evaluation of benign or malignant cardiac or pericardial masses, and SUVmean and MTV had the highest diagnostic accuracy. Therefore, PET/CT metabolic parameters can semi-quantitatively evaluate the benign or malignant cardiac/pericardial masses.

摘要

本研究旨在评估 PET/CT 代谢参数对半定量区分心脏或心包良恶性肿块的诊断性能。共招募了 41 例新诊断为心脏/心包肿块的患者进行 F-FDG PET/CT 检查。测量或计算 PET/CT 代谢参数,包括最大标准化摄取值(SUVmax)、平均标准化摄取值(SUVmean)、总病变糖酵解(TLG)、肿瘤代谢体积(MTV)、最大肿瘤-纵隔背景比(TMR)和最大肿瘤-肝脏背景比(TLR),以评估心脏/心包肿块的良恶性。与良性心脏/心包病变相比,心脏/心包恶性肿瘤的 SUVmax、SUVmean、TLG、MTV、TMR 和 TLR 均较高。所有这些 PET/CT 代谢参数在半定量评估心脏或心包良恶性肿块方面均具有较高的诊断性能,SUVmean 和 MTV 具有最高的诊断准确性。因此,PET/CT 代谢参数可对半定量评估心脏/心包良恶性肿块。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc17/11251084/5eb44b98305a/41598_2024_67336_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc17/11251084/9cee6659a7a5/41598_2024_67336_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc17/11251084/661518d85e31/41598_2024_67336_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc17/11251084/3233fad4173b/41598_2024_67336_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc17/11251084/5eb44b98305a/41598_2024_67336_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc17/11251084/9cee6659a7a5/41598_2024_67336_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc17/11251084/661518d85e31/41598_2024_67336_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc17/11251084/3233fad4173b/41598_2024_67336_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc17/11251084/5eb44b98305a/41598_2024_67336_Fig4_HTML.jpg

相似文献

1
F-FDG PET/CT metabolic parameters can semi-quantitatively evaluate the nature of the heart and pericardial masses: a retrospective study.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描代谢参数可半定量评估心脏和心包肿块的性质:一项回顾性研究。
Sci Rep. 2024 Jul 15;14(1):16316. doi: 10.1038/s41598-024-67336-8.
2
Diagnostic Accuracy of Cardiac Computed Tomography and 18-F Fluorodeoxyglucose Positron Emission Tomography in Cardiac Masses.心脏肿块的心脏计算机断层扫描和 18-F 氟脱氧葡萄糖正电子发射断层扫描的诊断准确性。
JACC Cardiovasc Imaging. 2020 Nov;13(11):2400-2411. doi: 10.1016/j.jcmg.2020.03.021. Epub 2020 Jun 17.
3
F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study.F-FDG PET/CT在心脏肿块患者诊断和预后评估中的应用:一项回顾性研究
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1083-1093. doi: 10.1007/s00259-019-04632-w. Epub 2019 Dec 5.
4
Improving the imaging diagnostic strategy for pulmonary artery masses based on F-FDG PET/CT integrated with CTPA.基于F-FDG PET/CT与CTPA相结合改善肺动脉肿块的影像诊断策略。
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4109-4121. doi: 10.1007/s00259-022-05851-4. Epub 2022 Jun 23.
5
Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.18F-FDG PET/CT参数及总病变糖酵解在鉴别肾上腺良恶性病变中的诊断价值
Nucl Med Commun. 2017 Sep;38(9):788-794. doi: 10.1097/MNM.0000000000000712.
6
Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma.基于氟-18-氟代脱氧葡萄糖 PET/CT 参数对甲状腺偶发瘤进行特征分析的诊断价值。
Korean J Radiol. 2018 Mar-Apr;19(2):342-351. doi: 10.3348/kjr.2018.19.2.342. Epub 2018 Feb 22.
7
The clinical value of texture analysis of dual-time-point F-FDG-PET/CT imaging to differentiate between F-FDG-avid benign and malignant pulmonary lesions.双时相 F-FDG-PET/CT 纹理分析在鉴别 F-FDG 摄取的肺良恶性病变中的临床价值。
Eur Radiol. 2020 Mar;30(3):1759-1769. doi: 10.1007/s00330-019-06463-7. Epub 2019 Nov 14.
8
Correlation between semiquantitative and volumetric 18F-FDG PET/computed tomography parameters and Ki-67 expression in breast cancer.乳腺癌半定量和容积 18F-FDG PET/CT 参数与 Ki-67 表达的相关性。
Nucl Med Commun. 2021 Jun 1;42(6):656-664. doi: 10.1097/MNM.0000000000001376.
9
Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.预处理代谢肿瘤体积和 18F-FDG PET/CT 总病变糖酵解对接受抗血管内皮生长因子靶向药物治疗的转移性肾细胞癌患者的预后价值。
Clin Nucl Med. 2017 May;42(5):e235-e241. doi: 10.1097/RLU.0000000000001612.
10
An Investigation of the Relationship Between F-FDG PET/CT Parameters of Primary Tumors and Lymph Node Metastasis in Resectable Non-small Cell Lung Cancer.可切除非小细胞肺癌中原发性肿瘤的F-FDG PET/CT参数与淋巴结转移关系的研究
Curr Radiopharm. 2024;17(1):111-116. doi: 10.2174/1874471016666230829100703.

引用本文的文献

1
Recurrent Acute Pericarditis Complicated by Constriction in T-Cell Acute Lymphoblastic Leukemia: Role of Multimodality Imaging.T细胞急性淋巴细胞白血病合并缩窄性复发性急性心包炎:多模态成像的作用
JACC Case Rep. 2025 Jun 25;30(16):104160. doi: 10.1016/j.jaccas.2025.104160.
2
[F]FDG PET imaging in the differentiation of cardiac masses: an updated systematic review and dual Meta-Analysis of diagnostic performance and parameter variability.[F]氟代脱氧葡萄糖正电子发射断层扫描成像在心脏肿块鉴别诊断中的应用:诊断性能及参数变异性的最新系统评价与双元荟萃分析
Eur J Nucl Med Mol Imaging. 2025 Apr 29. doi: 10.1007/s00259-025-07289-w.

本文引用的文献

1
Primary Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma of Lower Limb Muscles on 18 F-FDG PET/CT.18F-FDG PET/CT检查发现的下肢肌肉原发性结外鼻型自然杀伤/T细胞淋巴瘤
Clin Nucl Med. 2024 Jan 1;49(1):e45-e46. doi: 10.1097/RLU.0000000000004959. Epub 2023 Nov 16.
2
FDG PET/CT Prognostic Markers in Patients with Advanced Melanoma Treated with Ipilimumab and Nivolumab.接受伊匹单抗和纳武单抗治疗的晚期黑色素瘤患者的 FDG PET/CT 预后标志物。
Radiology. 2023 May;307(3):e221180. doi: 10.1148/radiol.221180. Epub 2023 Feb 28.
3
Qualitative and Semiquantitative Parameters of F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule.
F-FDG-PET/CT的定性和半定量参数作为孤立性肺结节患者恶性肿瘤的预测指标
Cancers (Basel). 2023 Feb 4;15(4):1000. doi: 10.3390/cancers15041000.
4
A comparison study of monoexponential and fractional order calculus diffusion models and F-FDG PET in differentiating benign and malignant solitary pulmonary lesions and their pathological types.单指数和分数阶微积分扩散模型与F-FDG PET在鉴别良性和恶性孤立性肺病变及其病理类型中的比较研究
Front Oncol. 2022 Jul 21;12:907860. doi: 10.3389/fonc.2022.907860. eCollection 2022.
5
Cardiac myxomas: A narrative review.心脏黏液瘤:一篇叙述性综述。
World J Cardiol. 2022 Apr 26;14(4):206-219. doi: 10.4330/wjc.v14.i4.206.
6
The Diagnostic Performance of Maximum Uptake Value and Apparent Diffusion Coefficient in Differentiating Benign and Malignant Ovarian or Adnexal Masses: A Meta-Analysis.最大摄取值和表观扩散系数在鉴别卵巢或附件良恶性肿块中的诊断性能:一项荟萃分析
Front Oncol. 2022 Feb 9;12:840433. doi: 10.3389/fonc.2022.840433. eCollection 2022.
7
Cardiovascular magnetic resonance of cardiac tumors and masses.心脏肿瘤和肿块的心血管磁共振成像
World J Cardiol. 2021 Nov 26;13(11):628-649. doi: 10.4330/wjc.v13.i11.628.
8
Indirect comparison of the diagnostic performance of F-FDG PET/CT and MRI in differentiating benign and malignant ovarian or adnexal tumors: a systematic review and meta-analysis.F-FDG PET/CT 与 MRI 鉴别卵巢或附件良恶性肿瘤的诊断性能的间接比较:系统评价和荟萃分析。
BMC Cancer. 2021 Oct 6;21(1):1080. doi: 10.1186/s12885-021-08815-3.
9
Incremental Value of FDG-PET in the Evaluation of Cardiac Masses.FDG-PET 在评估心脏肿块中的增值作用。
Curr Cardiol Rep. 2021 Jun 3;23(7):78. doi: 10.1007/s11886-021-01509-z.
10
Role of F-FDG PET/CT imaging in cardiac and pericardial masses.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描成像在心脏和心包肿块中的作用。
J Nucl Cardiol. 2022 Jun;29(3):1293-1303. doi: 10.1007/s12350-020-02510-9. Epub 2021 Jan 18.